# Study of ZGGS15 in Patients With Advanced Solid Tumors

> **NCT05864573** · PHASE1 · COMPLETED · sponsor: **Suzhou Zelgen Biopharmaceuticals Co.,Ltd** · enrollment: 22 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **BIOLOGICAL:** ZGGS15

## Key facts

- **NCT ID:** NCT05864573
- **Lead sponsor:** Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-19
- **Primary completion:** 2025-06-26
- **Final completion:** 2025-06-26
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05864573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05864573, "Study of ZGGS15 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT05864573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*